The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2018 | What trial data in CLL to watch out for at ASH 2018
With so many exciting chronic lymphocytic leukemia (CLL) trials ongoing, the data to be presented at the upcoming American Society of Hematology (ASH) 2018 Annual Meeting and Exposition is highly anticipated. We spoke to Stephan Stilgenbauer, MD, of the University of Ulm, Ulm, Germany, about the trials to watch out for at ASH 2018, including CLL14 (NCT02242942), iLLUMINATE (NCT02264574) and ALLIANCE A041202 (NCT01886872). This interview took place at the European Research Initiative on CLL (ERIC) International Meeting 2018, held in Barcelona, Spain.
